{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:27:41Z","timestamp":1786537661746,"version":"build-2736575974"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bioorg.2022.105816","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T17:28:00Z","timestamp":1650130080000},"page":"105816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation"],"prefix":"10.1016","volume":"124","author":[{"given":"Mohamed","family":"Reda Aouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshal A.","family":"Almehmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzia","family":"Faleh Albelwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Teleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina N.","family":"Tageldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Abu-Serie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadjet","family":"Rezki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","article-title":"Targeting metalloenzymes for therapeutic intervention","volume":"119","author":"Chen","year":"2018","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.cb.09.110193.002545","article-title":"Tumor cell interactions with the extracellular matrix during invasion and metastasis","volume":"9","author":"Stetler-Stevenson","year":"1993","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.bioorg.2022.105816_b0020","doi-asserted-by":"crossref","unstructured":"C. Walker, E. Mojares, A. del R\u00edo Hern\u00e1ndez, Role of extracellular matrix in development and cancer progression, Int J Mol Sci 19(10) (2018) 3028.","DOI":"10.3390\/ijms19103028"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","article-title":"Targeting matrix metalloproteinases in cancer: bringing new life to old ideas","volume":"2","author":"Cathcart","year":"2015","journal-title":"Genes & diseases"},{"issue":"24","key":"10.1016\/j.bioorg.2022.105816_b0030","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1158\/1078-0432.CCR-04-0424","article-title":"Matrix metalloproteinase\/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers","volume":"10","author":"Curran","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105816_b0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y99-055","article-title":"Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis","volume":"77","author":"Forget","year":"1999","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.105816_b0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2017.02.014","article-title":"Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview","volume":"129","author":"Adhikari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105816_b0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"issue":"3\u20134","key":"10.1016\/j.bioorg.2022.105816_b0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biochi.2004.11.019","article-title":"Crystal structures of MMPs in complex with physiological and pharmacological inhibitors","volume":"87","author":"Maskos","year":"2005","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases","volume":"27","author":"Schlechter","year":"1967","journal-title":"I, Biochem. Biophys. Res. Commun."},{"issue":"7015","key":"10.1016\/j.bioorg.2022.105816_b0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.bioorg.2022.105816_b0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2022.105816_b0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/1568026043387854","article-title":"Quest for selectivity in inhibition of matrix metalloproteinases","volume":"4","author":"Brown","year":"2004","journal-title":"Curr. Top Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105816_b0080","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161207781039706","article-title":"Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors","volume":"13","author":"Nuti","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"19","key":"10.1016\/j.bioorg.2022.105816_b0085","doi-asserted-by":"crossref","first-page":"8781","DOI":"10.1016\/j.bmc.2008.08.058","article-title":"Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge","volume":"16","author":"Georgiadis","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1381612053382115","article-title":"Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies","volume":"11","author":"Rao","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"19","key":"10.1016\/j.bioorg.2022.105816_b0095","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.3390\/ijms221910324","article-title":"Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2\/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation","volume":"22","author":"Albelwi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2022.105816_b0100","doi-asserted-by":"crossref","first-page":"113558","DOI":"10.1016\/j.ejmech.2021.113558","article-title":"Halting colorectal cancer metastasis via novel dual nanomolar MMP-9\/MAO-A quinoxaline-based inhibitors; Design, synthesis, and evaluation","volume":"222","author":"Ayoup","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0105","doi-asserted-by":"crossref","first-page":"111875","DOI":"10.1016\/j.ejmech.2019.111875","article-title":"Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K\/AKT signaling attenuation and caspase 3\/7 activation via Ugi bis-amide synthesis","volume":"186","author":"Ayoup","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2022.105816_b0110","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1074\/mcp.M000050-MCP201","article-title":"Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics","volume":"9","author":"Prudova","year":"2010","journal-title":"Mol. Cell Proteom"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases","volume":"42","author":"Cauwe","year":"2007","journal-title":"Crit Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"39","key":"10.1016\/j.bioorg.2022.105816_b0130","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.M201674200","article-title":"Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165","volume":"277","author":"Hashimoto","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0135","first-page":"1081","article-title":"MMP-2 alters VEGF expression via \u03b1V\u03b23 integrin-mediated PI3K\/AKT signaling in A549 lung cancer cells","volume":"127","author":"Chetty","year":"2010","journal-title":"Int. J. Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105816_b0140","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.onc.1206879","article-title":"Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis","volume":"23","author":"Heroult","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/cancers10060185","article-title":"Cutting to the chase: how matrix metalloproteinase-2 activity controls breast-cancer-to-bone metastasis","volume":"10","author":"Tauro","year":"2018","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/prot.340040406","article-title":"Refined structure of human carbonic anhydrase II at 2.0 \u00c5 resolution","volume":"4","author":"Eriksson","year":"1988","journal-title":"Proteins: Struct. Funct. Genet"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-019-0478-4","article-title":"Carbonic anhydrase 2 (CA II) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment","volume":"17","author":"Annan","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bioorg.2022.105816_b0170","doi-asserted-by":"crossref","first-page":"113260","DOI":"10.1016\/j.ejmech.2021.113260","article-title":"Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II","volume":"214","author":"Lenci","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105816_b0175","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3748\/wjg.v19.i16.2473","article-title":"Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0180","first-page":"743","article-title":"Carbonic anhydrase II","volume":"23","author":"Parkkila","year":"2010","journal-title":"A novel biomarker for gastrointestinal stromal tumors, Mod. Pathol."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105816_b0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/BF02389687","article-title":"Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours","volume":"27","author":"Parkkila","year":"1995","journal-title":"Histochem. J."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00006676-199009000-00002","article-title":"Carbonic anhydrase II gene expression in cell lines from human pancreatic adenocarcinoma","volume":"5","author":"Frazier","year":"1990","journal-title":"Pancreas"},{"issue":"34","key":"10.1016\/j.bioorg.2022.105816_b0195","first-page":"998","article-title":"Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer","volume":"47","author":"Bekku","year":"2000","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0200","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc. Natl. Acad Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00243908","article-title":"Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours","volume":"27","author":"Parkkila","year":"1995","journal-title":"Histochem. J."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0210","first-page":"5721","article-title":"Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0215","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1124\/mol.105.016519","article-title":"A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells","volume":"68","author":"Mallory","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105816_b0220","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The rebirth of matrix metalloproteinase inhibitors: Moving beyond the dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/1062936X.2017.1406986","article-title":"Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors","volume":"29","author":"Jha","year":"2018","journal-title":"SAR QSAR Environ. Res."},{"issue":"29","key":"10.1016\/j.bioorg.2022.105816_b0230","doi-asserted-by":"crossref","first-page":"27009","DOI":"10.1074\/jbc.M301139200","article-title":"Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2)","volume":"278","author":"Rosenblum","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acs.jmedchem.7b01091","article-title":"Discovery of novel potent VEGFR-2 inhibitors exerting significant antiproliferative activity against cancer cell lines","volume":"61","author":"Zhang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105816_b0240","doi-asserted-by":"crossref","first-page":"19361","DOI":"10.3390\/molecules201019361","article-title":"Design, synthesis, activity and docking study of sorafenib analogs bearing sulfonylurea unit","volume":"20","author":"Wu","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24460","article-title":"Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents","volume":"6","author":"Aziz","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0250","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1080\/14756366.2019.1651723","article-title":"Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities","volume":"34","author":"Jaballah","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","article-title":"Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor","volume":"356","author":"Roskoski","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2022.105816_b0260","doi-asserted-by":"crossref","first-page":"103123","DOI":"10.1016\/j.bioorg.2019.103123","article-title":"Ureidobenzenesulfonamides as efficient inhibitors of carbonic anhydrase II","volume":"91","author":"Serbian","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0265","doi-asserted-by":"crossref","first-page":"131145","DOI":"10.1016\/j.molstruc.2021.131145","article-title":"Designing Novel anticancer Sulfonamide based 2, 5-disubstituted-1, 3, 4-thiadiazole derivatives as Potential carbonic anhydrase inhibitor","volume":"1246","author":"Abas","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"33","key":"10.1016\/j.bioorg.2022.105816_b0270","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.2174\/0929867325666180607094856","article-title":"Dual inhibitors as a new challenge for cancer multidrug resistance treatment","volume":"26","author":"Stankovi\u0107","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2022.105816_b0275","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.bioorg.2022.105816_b0280","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery: miniperspective","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tips.2004.12.002","article-title":"Overcoming limitations of natural anticancer drugs by combining with artificial agents","volume":"26","author":"Blagosklonny","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105816_b0290","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.bmcl.2014.04.077","article-title":"Dual carbonic anhydrase\/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors","volume":"24","author":"Tauro","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105816_b0295","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.bmcl.2010.04.109","article-title":"New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors","volume":"20","author":"Esteves","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105816_b0300","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/jm000027t","article-title":"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2022.105816_b0305","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1021\/jm300981b","article-title":"Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2 Toward nontoxic chemotherapy targeting tumor microenvironment","volume":"55","author":"Reich","year":"2012","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105816_b0310","doi-asserted-by":"crossref","first-page":"127467","DOI":"10.1016\/j.bmcl.2020.127467","article-title":"Discovery of a D-pro-lys peptidomimetic inhibitor of MMP9: addressing the gelatinase selectivity beyond S1\u2032 subsite","volume":"30","author":"Lenci","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105816_b0315","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bmc.2019.03.043","article-title":"Identification of highly potent and selective MMP2 inhibitors addressing the S1\u2032 subsite with d-proline-based compounds","volume":"27","author":"Lenci","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1039\/C4MD00287C","article-title":"A study of ad-proline peptidomimetic inhibitor of melanoma and endothelial cell invasion through activity towards MMP-2 and MMP-9","volume":"6","author":"Bianchini","year":"2015","journal-title":"MedChemComm."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"issue":"5564","key":"10.1016\/j.bioorg.2022.105816_b0330","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer\u2014trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0335","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/13543776.15.3.253","article-title":"Recent non-hydroxamate matrix metalloproteinase inhibitors","volume":"15","author":"Breuer","year":"2005","journal-title":"Expert Opin Ther Pat."},{"key":"10.1016\/j.bioorg.2022.105816_b0340","doi-asserted-by":"crossref","unstructured":"M. Whittaker, C.D. Floyd, P. Brown, A.J. Gearing, Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors.(Chem. Rev. 1999, 99, 2735\u2212 2776. Published on the Web September 8, 1999), Chem Rev 101(7) (2001) 2205-2206.","DOI":"10.1021\/cr0100345"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0345","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","article-title":"Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","volume":"6","author":"Overall","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2022.105816_b0350","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1387\/ijdb.041811af","article-title":"Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies","volume":"48","author":"Folgueras","year":"2004","journal-title":"Int. J. Dev. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0355","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Cell Res."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105816_b0360","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.bmcl.2005.05.079","article-title":"Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors","volume":"15","author":"Dublanchet","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"38","key":"10.1016\/j.bioorg.2022.105816_b0365","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/jm701274v","article-title":"Quinazolinones and pyrido [3, 4-d] pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis","volume":"51","author":"Li","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0375","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jmb.2004.06.039","article-title":"Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12","volume":"341","author":"Morales","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105816_b0380","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0385","doi-asserted-by":"crossref","first-page":"111843","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0390","doi-asserted-by":"crossref","first-page":"104330","DOI":"10.1016\/j.bioorg.2020.104330","article-title":"Discovery of novel indolyl-1, 2, 4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity","volume":"105","author":"Al-Hussain","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0395","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bioorg.2018.10.071","article-title":"Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity","volume":"82","author":"Elsayed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0400","doi-asserted-by":"crossref","first-page":"103189","DOI":"10.1016\/j.bioorg.2019.103189","article-title":"Dual VEGFR-2\/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: design, synthesis and biological evaluation","volume":"92","author":"Rizk","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0405","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bioorg.2018.10.042","article-title":"Synthesis of 1, 2, 4-triazole-5-on derivatives and determination of carbonic anhydrase II isoenzyme inhibition effects","volume":"83","author":"Akin","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jmbi.1993.1365","article-title":"Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1, 2, 4-triazole","volume":"232","author":"Mangani","year":"1993","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0415","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0167-4838(85)90189-X","article-title":"The inhibition of human carbonic anhydrase II by some organic compounds","volume":"829","author":"Tibell","year":"1985","journal-title":"biochim biophys acta, protein struct. Mol. Enzymol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0420","doi-asserted-by":"crossref","first-page":"e22239","DOI":"10.1002\/jbt.22239","article-title":"In vitro cytotoxic and in vivo antitumoral activities of some aminomethyl derivatives of 2, 4-dihydro-3H-1, 2, 4-triazole-3-thiones\u2014Evaluation of their acetylcholinesterase and carbonic anhydrase enzymes inhibition profiles","volume":"33","author":"Timur","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"38","key":"10.1016\/j.bioorg.2022.105816_b0425","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1039\/c3ob41046c","article-title":"Progress towards water-soluble triazole-based selective MMP-2 inhibitors","volume":"11","author":"Fabre","year":"2013","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105816_b0430","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2022.105816_b0435","first-page":"104835","article-title":"Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7\/HepG2 cytotoxicity: Synthesis","volume":"111","author":"Ihmaid","year":"2021","journal-title":"EGFR inhibitory effect, and metabolic stability, Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0440","doi-asserted-by":"crossref","first-page":"129192","DOI":"10.1016\/j.molstruc.2020.129192","article-title":"Design, click conventional and microwave syntheses, DNA binding, docking and anticancer studies of benzotriazole-1, 2, 3-triazole molecular hybrids with different pharmacophores","volume":"1225","author":"Alraqa","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2022.105816_b0445","doi-asserted-by":"crossref","first-page":"129148","DOI":"10.1016\/j.molstruc.2020.129148","article-title":"Design, synthesis, DNA binding, modeling, anticancer studies and DFT calculations of Schiff bases tethering benzothiazole-1, 2, 3-triazole conjugates","volume":"1225","author":"Almehmadi","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2022.105816_b0450","doi-asserted-by":"crossref","unstructured":"A. Aljuhani, M.A. Almehmadi, I.O. Barnawi, N. Rezki, I. Ali, M. Messali, M.R. Aouad, Microwave versus conventional synthesis, anticancer, DNA binding and docking studies of some 1, 2, 3-triazoles carrying benzothiazole, Arab J Chem 14(3) (2021) 102997.","DOI":"10.1016\/j.arabjc.2021.102997"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0455","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsomega.0c04595","article-title":"Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives","volume":"6","author":"Al Sheikh Ali","year":"2021","journal-title":"ACS Omega"},{"issue":"36","key":"10.1016\/j.bioorg.2022.105816_b0460","first-page":"11347","article-title":"Synthesis, Characterization, DNA Binding, Docking, and Anticancer Studies of Novel Bis-1, 2, 3-triazoles Phthalonitrile","volume":"5","author":"Yahya Alraqa","year":"2020","journal-title":"Chem. Select"},{"key":"10.1016\/j.bioorg.2022.105816_b0465","doi-asserted-by":"crossref","first-page":"104133","DOI":"10.1016\/j.bioorg.2020.104133","article-title":"Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1, 2, 3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: synthesis, antitumor and mechanistic analyses","volume":"103","author":"Rezki","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0479-1","article-title":"Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1, 2, 3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents","volume":"12","author":"Al-Blewi","year":"2018","journal-title":"Chem. Cent. J."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd2796","article-title":"The influence of lead discovery strategies on the properties of drug candidates","volume":"8","author":"Keser\u00fc","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.105816_b0480","series-title":"The Practice of Medicinal Chemistry (Fourth Edition)","first-page":"379","article-title":"Chapter 15 - Compound Properties and their Influence on Drug Quality","author":"Chen","year":"2015"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105816_b0485","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/jm701255b","article-title":"Ligand Binding Efficiency: Trends, Physical Basis, and Implications","volume":"51","author":"Reynolds","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0490","doi-asserted-by":"crossref","unstructured":"L.F. Awad, M. Teleb, N.A. Ibrahim, M.M. Abu-Serie, M.N. Abd Al Moaty, Structure-based design and optimization of pyrimidine-and 1, 2, 4-triazolo [4, 3-a] pyrimidine-based matrix metalloproteinase-10\/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology, Bioorg Chem 96 (2020) 103616.","DOI":"10.1016\/j.bioorg.2020.103616"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0495","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0500","first-page":"31","article-title":"Lipophilicity indices for drug development","volume":"1","author":"Arnott","year":"2013","journal-title":"J. Appl. Biopharm. Pharmacokinet"},{"issue":"7","key":"10.1016\/j.bioorg.2022.105816_b0505","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/jm201705f","article-title":"Structure-Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein","volume":"55","author":"Jabeen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0510","unstructured":"C.C.G. Molecular Operating Environment (MOE), Montreal, Canada, http:\/\/www.chemcomp.com."},{"issue":"1-2","key":"10.1016\/j.bioorg.2022.105816_b0515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0167-4838(02)00307-2","article-title":"Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor","volume":"1598","author":"Feng","year":"2002","journal-title":"Biochim Biophys Acta Proteins Proteom."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105816_b0520","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/pro.5560071201","article-title":"Structural analysis of inhibitor binding to human carbonic anhydrase II","volume":"7","author":"Boriack-Sjodin","year":"1998","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0525","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1093-3263(00)00040-1","article-title":"Docking of sulfonamides to carbonic anhydrase II and IV","volume":"18","author":"Esposito","year":"2000","journal-title":"J. Mol. Graph Model"},{"issue":"45","key":"10.1016\/j.bioorg.2022.105816_b0530","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad Sci."},{"key":"10.1016\/j.bioorg.2022.105816_b0535","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2017.04.068","article-title":"Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors","volume":"136","author":"Abdullaziz","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0540","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1248\/cpb.c18-00990","article-title":"A 3D-QSAR analysis of CDK2 inhibitors using FMO calculations and PLS regression","volume":"67","author":"Yoshida","year":"2019","journal-title":"Chem. Pharm. Bull"},{"key":"10.1016\/j.bioorg.2022.105816_b0545","doi-asserted-by":"crossref","first-page":"107599","DOI":"10.1016\/j.jmgm.2020.107599","article-title":"Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method","volume":"99","author":"Takaya","year":"2020","journal-title":"J. Mol. Graph. Model"},{"key":"10.1016\/j.bioorg.2022.105816_b0550","series-title":"2-(alkylthio)-3-(naphthalen-1-yl) quinazolin-4 (3 H)-ones: ultrasonic synthesis","first-page":"1","author":"Mohammed","year":"2021"},{"issue":"18","key":"10.1016\/j.bioorg.2022.105816_b0555","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1080\/07391102.2019.1701555","article-title":"A new chiral boron-dipyrromethene (BODIPY)-based fluorescent probe: Molecular docking DFT, antibacterial and antioxidant approaches","volume":"38","author":"Alnoman","year":"2020","journal-title":"J. Biomol. Struct."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0560","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/ijms22062807","article-title":"A New Family of Benzo [h] Chromene Based Azo Dye: Synthesis, In-Silico and DFT Studies with In Vitro Antimicrobial and Antiproliferative Assessment","volume":"22","author":"Abd-El-Aziz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2022.105816_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.672503","article-title":"Novel 2-Hydroselenonicotinonitriles and Selenopheno [2, 3-b] pyridines: Efficient Synthesis, Molecular Docking-DFT Modeling, and Antimicrobial Assessment","volume":"9","author":"Abdellattif","year":"2021","journal-title":"Front Chem."},{"issue":"37","key":"10.1016\/j.bioorg.2022.105816_b0570","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.1021\/ja952781n","article-title":"Molecular electrostatic potential analysis for enzymatic substrates, competitive inhibitors, and transition-state inhibitors","volume":"118","author":"Bagdassarian","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0575","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00894-002-0111-z","article-title":"Segmental analysis of molecular surface electrostatic potentials: application to enzyme inhibition","volume":"9","author":"Brinck","year":"2003","journal-title":"J Mol. Model"},{"key":"10.1016\/j.bioorg.2022.105816_b0580","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1289\/ehp.8561191","article-title":"Molecular electrostatic potentials: an effective tool for the elucidation of biochemical phenomena","volume":"61","author":"Politzer","year":"1985","journal-title":"Environ. Health Perspect"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0585","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/mp300537k","article-title":"In silico physicochemical parameter predictions","volume":"10","author":"Wenlock","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0590","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2022.105816_b0595","first-page":"1","article-title":"Design and synthesis of new EGFR-tyrosine kinase inhibitors containing pyrazolo [3, 4-d] pyrimidine cores as anticancer agents","volume":"35","author":"Bakr","year":"2012","journal-title":"Bull Pharm. Sci. Assiut. Univ"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105816_b0600","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12039-013-0485-8","article-title":"Design, synthesis and cytotoxic activity of some novel compounds containing pyrazolo [3, 4-d] pyrimidines nucleus","volume":"125","author":"Kandeel","year":"2013","journal-title":"J. Chem. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0605","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/03602530903118729","article-title":"New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme","volume":"41","author":"Wang","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105816_b0610","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1023\/A:1012102522787","article-title":"In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man\u2014fact or myth","volume":"14","author":"Yee","year":"1997","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0615","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1745-7254.2005.00068.x","article-title":"Predictive model of blood-brain barrier penetration of organic compounds","volume":"26","author":"Ma","year":"2005","journal-title":"Acta. Pharmacologica. Sinica"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0620","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105816_b0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin\u2013Darby canine kidney) cells: A tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.bioorg.2022.105816_b0630","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1023\/A:1011930411574","article-title":"Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds","volume":"15","author":"Yazdanian","year":"1998","journal-title":"Pharm. Res."},{"issue":"W1","key":"10.1016\/j.bioorg.2022.105816_b0635","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.bioorg.2022.105816_b0640","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/acs.jmedchem.9b01004","article-title":"SAR Studies on aromatic acylhydrazone-based inhibitors of fungal sphingolipid synthesis as next-generation antifungal agents","volume":"62","author":"Haranahalli","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2022.105816_b0645","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2022.105816_b0650","doi-asserted-by":"crossref","first-page":"105262","DOI":"10.1016\/j.bioorg.2021.105262","article-title":"Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide","volume":"115","author":"El-Wakil","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0655","doi-asserted-by":"crossref","first-page":"113475","DOI":"10.1016\/j.ejmech.2021.113475","article-title":"Beyond direct Nrf2 activation; reinvestigating 1, 2, 4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy","volume":"220","author":"Ayoup","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0660","doi-asserted-by":"crossref","first-page":"105304","DOI":"10.1016\/j.bioorg.2021.105304","article-title":"Transforming Type II to Type I c-Met kinase inhibitors via combined scaffold hopping and structure-guided synthesis of new series of 1, 3, 4-thiadiazolo [2, 3-c]-1, 2, 4-triazin-4-one derivatives","volume":"116","author":"El-Wakil","year":"2021","journal-title":"Bioorg Chem"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105816_b0665","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal Biochem."},{"key":"10.1016\/j.bioorg.2022.105816_b0670","unstructured":"J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning: a laboratory manual, Cold spring harbor laboratory press1989."},{"key":"10.1016\/j.bioorg.2022.105816_b0675","unstructured":"https:\/\/www.abcam.com\/mmp2-inhibitor-screening-assay-kit-colorimetric-ab139446.html."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105816_b0680","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.arabjc.2015.02.024","article-title":"Alpha-glucosidase and carbonic anhydrase inhibition studies of Pd (II)-hydrazide complexes","volume":"10","author":"Qurrat-ul-Ain","year":"2017","journal-title":"Arab J. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105816_b0685","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11426-008-0133-1","article-title":"Screening and docking studies of natural phenolic inhibitors of carbonic anhydrase II","volume":"52","author":"Huang","year":"2009","journal-title":"Sci. China, Ser B: Chem."},{"key":"10.1016\/j.bioorg.2022.105816_b0690","unstructured":"http:\/\/bpsbioscience.com\/vegfr2-kdr-kinase-assay-kit-40325."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:33:40Z","timestamp":1758616420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822002218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":138,"alternative-id":["S0045206822002218"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105816","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105816"}}